The Supervisory Board of Finapolline, ACTEON Group's holding company, announces the appointment, effective June 1st, 2020, of Michael Rynerson as Chief Executive Officer of the ACTEON Group.
Vincent Ménez, Chairman of the Supervisory Board of Finapolline, says: "Michael Rynerson has over 25 years of experience in various senior executive positions for global hightechnology companies, notably in the dental industry, and the Supervisory Board considers that he holds all the skills required to lead the new phase of development of ACTEON, with the ambition to strengthen its global leadership in the fields of dental equipment, consumables and imaging.
Michael will ensure that the company emerges stronger from the current health and economic crisis and is best positioned to accompany the future evolutions of the dental industry. His extensive expertise in developing, manufacturing and distributing innovative technologies at a global scale will also be a valuable asset to accelerate ACTEON's development in the context of the digitalization of the dental industry.
Deeply acquainted with the European culture thanks to his education and past professional experience in Europe, Michael will undoubtedly be able to create a fruitful working relationship among the teams to foster the future success of ACTEON.”
Vincent Ménez adds: "I would like to sincerely thank Yann Gallard and the management team for their strong commitment which has allowed the company to run effectively during the transition period, and for their courage and ability to make the right decisions to address the current crisis.”
The Supervisory Committee renews its confidence in ACTEON's teams, and remains fully convinced by its human, technological and industrial assets, and long-term growth potential.
About ACTEON
ACTEON is a French MedTech company specializing in high-tech medical devices. Based in Mérignac, the Group has become a leading global player thanks to its cutting-edge innovative technology. ACTEON employs 820 people, almost half of whom are outside France. They are spread across 6 manufacturing plants, 7 branches and 8 representative offices established in the main global markets. The Group has a well-established and rigorous quality policy focused on customer satisfaction and innovation, in strict compliance with the applicable international regulations and standards. www.acteongroup.com.
